Danske Bank’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-600
Closed -$37K – 1456
2025
Q4
$37K Hold
600
– – ﹤0.01% 1070
2025
Q3
$37.4K Hold
600
– – ﹤0.01% 1073
2025
Q2
$47.9K Buy
+600
New +$50.2K ﹤0.01% 1040
2024
Q4
– Sell
-900
Closed -$64.9K – 1587
2024
Q3
$64.9K Buy
+900
New +$63.7K ﹤0.01% 1134

Other funds holding PBH

Danske Bank's PBH Position: Q1 2026 in Review

Danske Bank sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 600 shares — an estimated $37K sold.

Danske Bank first reported a position in PBH in Q3 2024 and held it in 4 quarters. The position peaked at $64.9K in Q3 2024. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Danske Bank reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 600 Prestige Consumer Healthcare shares in Q1 2026, an estimated $37K.
  • Danske Bank first reported a position in Prestige Consumer Healthcare in Q3 2024 and held it in 4 quarters.
  • Danske Bank's Prestige Consumer Healthcare position peaked at $64.9K in Q3 2024.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.